A UK health regulator has added an uncommon illness to the list of probable side effects from the AstraZaneca vaccination.
Guillain-Barre syndrome has been reported in some persons who have received the AstraZeneca vaccination, but experts say the benefits of the Covid vaccine much outweigh any potential negative effects.
Guillain-Barre syndrome has been added to the vaccine's list of possible side effects by the Medicines and Healthcare Products Regulatory Agency (MHRA).
According to the NHS, the disorder primarily affects the nerves in the feet, hands, and limbs.
Patients suffering from an immune system disorder may experience numbness, discomfort, or weakness.
Most people will be treated and recover completely, but in rare cases, it can cause long-term disease or even death.
Last month, the European Medicines Agency added Guillain-Barre syndrome to the vaccine's list of negative effects.
In context, as of July 31, 833 occurrences of the condition had been reported from 600 million AstraZeneca doses administered.
According to Prof Tim Spector, an epidemiologist at King's College London, the most prevalent side effect of the AstraZeneca vaccine is a headache, followed by fatigue.
He is a lead researcher on the ZOE Covid study, which looks into Covid symptoms and vaccine side effects.
Prof Spector compiled his list of typical adverse effects using data from app users.